Skip to main content
. 2017 Dec 13;81(1):49–58. doi: 10.4046/trd.2016.0056

Table 3. Baseline characteristics of patients with follow-up CT venography at 3–9 months (n=143).

DVT (n=13) Control (n=130) p-value
Age, yr 75 (68–79) 65 (55–72) 0.009
Male sex 1 (7.7) 49 (37.7) 0.034
Ever-smokers 2/13 (15.4) 35/126 (27.8) 0.513
Body mass index, kg/m2 23 (21–26) 25 (22–29) 0.405
Unprovoked PE 7 (53.8) 51 (39.2) 0.306
Risk factor for VTE
 Surgery or trauma 2 (15.4) 53 (40.8) 0.082
 Cancer 2 (15.4) 8 (6.2) 0.226
 Immobilization 4 (30.8) 65 (50.0) 0.248
 Previous VTE 0 (0) 4 (3.1) >0.999
Comorbid condition
 Diabetes mellitus 1 (7.7) 20 (15.4) 0.692
 Chronic lung disease* 2 (15.4) 9 (6.9) 0.262
 Stroke 2 (15.4) 10 (7.7) 0.299
 Heart disease 2 (15.4) 11 (8.5) 0.335
 Chronic kidney disease 1 (7.7) 3 (2.3) 0.320
 Arthritis 2 (15.4) 27 (20.8) >0.999
 Varicose vein 0 (0) 2 (1.5) >0.999
 Hormonal therapy 0 (0) 3 (2.3) >0.999
Systolic BP, mmHg 120 (113–147) 125 (111–140) 0.746
 <90 1 (7.7) 0 (0) 0.091
Heart rate, /min 87 (71–109) 84 (74–98) 0.938
 Tachycardia, heart rate >110/min 3 (23.1) 9 (6.9) 0.080
PESI 81 (71–99) 71 (60–83) 0.036
 PESI class IV–V 1 (7.7) 10 (7.7) >0.999
Thrombolytic therapy 1 (7.7) 5 (3.8) 0.442
Vena cava filter insertion 0 (0) 1 (0.8) >0.999
VTE recurrence 2 (15.4) 12 (9.2) 0.617
Adverse outcome 1 (7.7) 6 (4.6) 0.495
NT-proBNP, pg/mL 1,169 (245–2,246) 244 (66–1,508)§ 0.190
Troponin I, ng/mL 0.040 (0.040–0.110) 0.040 (0.015–0.129) 0.410
Time interval of CT scans, day 123 (104–197) 146 (104–189) 0.950
Central PE** 9 (69.2) 43 (33.1) 0.015
RV/LV diameter ratio 1.06 (0.76–1.30) 0.92 (0.76–1.10) 0.461
RV dilation on initial CT 8 (61.5) 51 (39.2) 0.119
DVT at initial presentation 11/13 (84.6) 95/122 (77.9) 0.734
Proximal DVT at initial presentation 7/13 (53.8) 65/122 (53.3) 0.969

Values are presented as median (interquartile range) or number (%).

CT: computed tomography; DVT: deep vein thrombosis; PE: pulmonary embolism; VTE: venous thromboembolism; BP: blood pressure; PESI: pulmonary embolism severity index; NT-proBNP: N-terminal-pro-B-type natriuretic peptide; RV: right ventricle; LV: left ventricle.

*Chronic lung disease includes chronic obstructive pulmonary disease, asthma, bronchiectasis, idiopathic pulmonary fibrosis, pneumoconiosis, and tuberculosis-destroyed lung. Heart disease includes ischemic heart disease, congestive heart failure, and atrial fibrillation. n=10. §n=85. n=11. n=103. **Central pulmonary arteries mean right or left pulmonary artery or more proximal location.